GE HealthCare Technologies Inc. (GEHC)
| Market Cap | 33.80B +0.1% |
| Revenue (ttm) | 21.27B +6.5% |
| Net Income | 1.99B -11.4% |
| EPS | 4.34 -11.1% |
| Shares Out | 451.69M |
| PE Ratio | 17.24 |
| Forward PE | 14.46 |
| Dividend | $0.14 (0.19%) |
| Ex-Dividend Date | Jul 24, 2026 |
| Volume | 2,247,350 |
| Open | 74.16 |
| Previous Close | 74.06 |
| Day's Range | 73.69 - 75.01 |
| 52-Week Range | 58.75 - 89.77 |
| Beta | 0.82 |
| Analysts | Buy |
| Price Target | 82.50 (+10.27%) |
| Earnings Date | Jul 29, 2026 |
About GEHC
GE HealthCare Technologies Inc. engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Advanced Visualization Solutions (AVS), Patient Care Solutions (PCS), and Pharmaceutical Diagnostics (PDx). The Imaging segment offers molecular imaging, computed tomography (CT) scanning, magnetic resonance (MR) imaging, X-ray systems, an... [Read more]
Financial Performance
In 2025, GEHC's revenue was $20.63 billion, an increase of 4.84% compared to the previous year's $19.67 billion. Earnings were $2.08 billion, an increase of 4.57%.
Financial StatementsAnalyst Summary
According to 19 analysts, the average rating for GEHC stock is "Buy." The 12-month stock price target is $82.5, which is an increase of 10.27% from the latest price.
News
GE HealthCare appoints William Grogan as CFO, replacing Jay Saccaro
GE HealthCare said on Tuesday it had appointed William Grogan chief financial officer, effective September 14, succeeding Jay Saccaro after he stepped down last month.
GE HealthCare appoints William Grogan as Chief Financial Officer
CHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC), a leading global precision care innovator, today announced the appointment of William (Bill) Grogan as Chief Financial Officer, effective Septem...
GE HealthCare expands the LOGIQ e ultrasound platform with new LOGIQ e family
CHICAGO--(BUSINESS WIRE)--GE HealthCare today announced the introduction of the LOGIQ™ e family, featuring LOGIQ™ e Xi and LOGIQ™ e Si, two compact laptop ultrasound systems designed to help clinician...
GE HealthCare expands breast imaging portfolio with Invenia ABUS Prime and launch of ABUS StreamVue
CHICAGO--(BUSINESS WIRE)--GE HealthCare today announced the launch of Invenia™ ABUS (Automated Breast Ultrasound) Prime and ABUS StreamVue™, a redesigned enterprise viewer that recently received U.S. ...
GE HealthCare Technologies Earnings Call Transcript: Q2 2026
Orders grew 11% year-over-year with record backlog, and revenue rose 3.5% organically, driven by strong performance in Advanced Imaging and Pharmaceutical Diagnostics. PCS faced operational challenges but is expected to recover in the second half. Full-year guidance is maintained.
GE HealthCare Technologies Slides: Q2 2026
GE HealthCare Technologies has posted slides in relation to its Q2 2026 quarterly earnings report, which was published on July 29, 2026.
GE HealthCare Technologies Earnings release: Q2 2026
GE HealthCare Technologies released its Q2 2026 earnings on July 29, 2026, summarizing the period's financial results.
GE HealthCare Technologies Quarterly report: Q2 2026
GE HealthCare Technologies has published its Q2 2026 quarterly earnings report on July 29, 2026.
GE HealthCare Stock Soars After Earnings. Here's What Drove the Profit Gains.
GE HealthCare reports earnings per share of $1.13 from sales of $5.3 billion. Wall Street was looking for $1.04 a share and $5.3 billion, respectively.
GE HealthCare beats quarterly profit estimates on strong imaging demand, tariff refunds
GE HealthCare on Wednesday beat Wall Street estimates for second-quarter profit, helped by strong demand for its diagnostic and imaging devices and refunds of tariffs imposed under U.S. President Don...
GE HealthCare Posts Higher Profit, Revenue on Increased Orders
GE HealthCare Technologies notched higher profit and revenue in the second quarter, boosted by increased orders across the business.
GE HealthCare reports second quarter 2026 financial results
CHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) today reported financial results for the second quarter ended June 30, 2026. GE HealthCare President and CEO Peter Arduini said, “We delivered re...
GE HealthCare CFO to step down
GE HealthCare said on Thursday that its Chief Financial Officer Jay Saccaro will step down from his role to pursue an opportunity outside the medical technology industry.
GE HealthCare announces CFO transition; reports preliminary second quarter 2026 financial results and reaffirms guidance reflecting business momentum
CHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) today announced that Jay Saccaro will step down as Vice President and Chief Financial Officer for an expanded role outside of the medical technol...
GE HealthCare introduces MIM Anyware to extend remote access to imaging data and optimize clinical collaboration
CHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) today announced the introduction of MIM Anyware™, a remote access platform that provides secure, healthcare system-controlled access to imaging d...
Catholic Health and GE HealthCare partner to expand patient access across Long Island
ROCKVILLE CENTRE, N.Y.--(BUSINESS WIRE)--Catholic Health, an integrated health system located on Long Island, NY, and GE HealthCare (Nasdaq: GEHC) announced today a 10-year strategic partnership, know...
GE HealthCare and Mayo Clinic aim to advance personalized cancer treatment through new theranostics research collaboration
CHICAGO & ROCHESTER, Minn.--(BUSINESS WIRE)--GE HealthCare and Mayo Clinic today announced the MI-BET (Molecular Imaging Biomarker-Based End of Therapy Trial) research collaboration, a novel theranost...
GE HealthCare to announce second quarter 2026 results on July 29, 2026
CHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) will announce its second quarter 2026 financial results before the market opens on Wednesday, July 29, 2026. The GE HealthCare management team wi...
GE HealthCare announces cash dividend for second quarter of 2026
CHICAGO--(BUSINESS WIRE)--The Board of Directors of GE HealthCare Technologies Inc. (Nasdaq: GEHC) today declared a cash dividend of $0.035 per share of Common Stock for the second quarter of 2026 pay...
GE HealthCare introduces Allia upgrade pathways designed to modernize existing interventional suites
CHICAGO--(BUSINESS WIRE)--GE HealthCare today announced Allia™ platform upgrade pathways designed to help customers modernize select legacy Innova™ and Discovery™ Image Guiding Solutions (IGS) systems...
GE HealthCare advancing enterprise imaging with cloud-enabled solutions
CHICAGO--(BUSINESS WIRE)--GE HealthCare will showcase its latest enterprise imaging solutions at the Society for Imaging Informatics in Medicine (SIIM) 2026 Annual Meeting in Pittsburgh, PA. Medical i...
GE HealthCare receives FDA 510(k) clearance for MIM Contour ProtégéAI+ 2.0, advancing AI-enabled radiation therapy planning with expanded clinical capabilities
CHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) today announced it has received 510(k) clearance from the United States Food and Drug Administration (FDA) for MIM Contour ProtégéAI+™ 2.0, an AI...
GE HealthCare Technologies Transcript: Jefferies Global Healthcare Conference 2026
Orders and backlog reached record levels, with robust demand and revenue growth driven by existing products. Inflation and memory chip costs led to a guidance reduction, but buffers and mitigation strategies are in place. New product launches and pipeline innovations are expected to accelerate growth, while Flyrcado and strategic M&A remain key priorities.
GE HealthCare Focuses on Expanding Access to Nuclear Medicine Through AI, Radiopharmaceutical and Imaging Innovations
CHICAGO--(BUSINESS WIRE)--As theranostics adoption acceleratesi and radiopharmaceutical demand grows,ii healthcare systems are under increasing pressure to scale nuclear medicine operations while impr...
GE HealthCare Technologies Transcript: Bank of America Global Healthcare Conference 2026
Guidance was reduced due to inflation and supply chain pressures, but EPS growth and margin improvement are expected through cost initiatives, pricing actions, and new product launches. Strategic restructuring, robust innovation, and strong market demand support a positive long-term outlook.